{
  "id": 10622552,
  "title": "Novo Nordisk strikes $2.6B obesity drug deal with China's Hengrui",
  "url": "https://urgent.news/2026/09/29/novo-nordisk-strikes-2-6b-obesity-drug-deal-with-chinas-hengrui",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-29T05:56:34.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4647845-novo-nordisk-strikes-26b-obesity-drug-deal-with-chinas-hengrui?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Hengrui Pharma shares rise as Novo Nordisk signs $2.6 billion drug deal",
        "url": "https://urgent.news/2026/09/29/hengrui-pharma-shares-rise-as-novo-nordisk-signs-2-6-billion-drug-deal",
        "published": "2026-09-29T05:16:50.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}